Literature DB >> 24503727

Remove, rotate, and reimplant: a novel technique for the management of exposed porous anophthalmic implants in eviscerated patients.

P Kaynak1, G O Karabulut1, C Ozturker1, I Perente2, B Gökyiǧit2, A Demirok3, O F Yilmaz2.   

Abstract

PURPOSE: To describe and to evaluate a new and relatively easy technique for porous implant exposure repair.
METHODS: Eleven patients with exposed porous orbital implants after evisceration were included in this study. Five patients with large exposures (diameter >7 mm) and six patients with small exposures of orbital implants (diameter <7 mm) that persisted despite posterior vaulting of the prosthesis and usage of antibiotics and steroids for more than 6 weeks, underwent revision surgery with the remove-rotate-reimplant technique (3R technique). Negative microbiological culture taken from the exposed socket surface before surgery was the major inclusion criterion. Five patients with insufficient conjunctival tissue also underwent additional mucosa or hard palate grafting of the defect in addition to the remove-rotate-reimplant procedure.
RESULTS: Patients have been followed up for more than 18 months (ranging from 18-30 months). None of them received motility peg insertion after repair. Implant reexposure was detected in one patient during the follow-up period, which was managed by dermis fat grafting with implant removal.
CONCLUSION: The remove-rotate-reimplant technique is an effective surgical method for repairing exposed porous anophthalmic implants after evisceration with a 90% success in this study. It avoids the removal of the implant from the sclera, which is a traumatic procedure that may lead to the tearing and loss of scleral tissue covering the implant. Saving the porous implant and scleral cover reduces the surgical time and cost.

Entities:  

Mesh:

Year:  2014        PMID: 24503727      PMCID: PMC4017112          DOI: 10.1038/eye.2014.2

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  27 in total

1.  Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.

Authors:  C L Shields; J A Shields; R C Eagle; P De Potter
Journal:  Am J Ophthalmol       Date:  1991-03-15       Impact factor: 5.258

2.  Coralline hydroxyapatite as an ocular implant.

Authors:  J J Dutton
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

Review 3.  Integrated orbital implants.

Authors:  A C Perry
Journal:  Adv Ophthalmic Plast Reconstr Surg       Date:  1990

4.  A simplified scleral graft technique for covering an exposed orbital implant.

Authors:  M F Goldberg
Journal:  Ophthalmic Surg       Date:  1988-03

5.  One-stage explant-implant procedure of exposed porous orbital implants.

Authors:  Peter B Toft; Marie L Roed Rasmussen; Jan U Prause
Journal:  Acta Ophthalmol       Date:  2010-05-26       Impact factor: 3.761

6.  A long-term follow-up study of scleral grafting for exposed or extruded orbital implants.

Authors:  J A Fountain; E M Helveston
Journal:  Am J Ophthalmol       Date:  1982-01       Impact factor: 5.258

7.  Long term follow up of bone derived hydroxyapatite orbital implants.

Authors:  A J Suter; A C B Molteno; T H Bevin; J D Fulton; P Herbison
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

8.  Clinicopathologic analysis of 15 explanted hydroxyapatite implants.

Authors:  David R Jordan; Seymour Brownstein; Hamid Faraji
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-07       Impact factor: 1.746

9.  Problems after evisceration surgery with porous orbital implants: experience with 86 patients.

Authors:  David R Jordan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-09       Impact factor: 1.746

10.  Tissue breakdown and exposure associated with orbital hydroxyapatite implants.

Authors:  H Buettner; G B Bartley
Journal:  Am J Ophthalmol       Date:  1992-06-15       Impact factor: 5.258

View more
  1 in total

1.  Helium-neon laser therapy in the treatment of hydroxyapatite orbital implant exposure: A superior option.

Authors:  Qi-Hua Xu; Chen Zhao; Jian-Gang Zhu; Mei-Juan Chen; Qing-Huai Liu
Journal:  Exp Ther Med       Date:  2015-06-23       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.